A cardioprotective agent of a novel calpain inhibitor,SNJ- 1945 exerts beta1-actions on left ventricular mechanical work and energetics.

A cardioprotective agent of a novel calpain inhibitor,SNJ- 1945 exerts beta1-actions on left ventricular mechanical work and energetics.
复制标题

SNJ-1945 是一种新型钙蛋白酶抑制剂的心脏保护剂,对左心室机械功和能量发挥 β1 作用。

DOI:
10.1152/ajpheart.00153.2010
复制
发表时间:
2010
期刊:
Am J Physiol Heart Physiol.
影响因子:
--
通讯作者:
他
他
中科院分区:
--
文献类型:
--
作者:
Yoshikawa Y;Obata K;Asada K;Takaki M;他

文献摘要

相似文献

我们以前已经证明,一种新开发的钙蛋白酶抑制剂,SNJ-1945(SNJ),具有良好的水溶性,防止心脏从氯化钾停搏-再灌注损伤与损害的总钙处理通过抑制α-胞衬蛋白作为心脏停搏液的蛋白水解。本研究的目的是研究钙蛋白酶抑制剂SNJ对交叉循环离体大鼠心脏进行40 μM SNJ血液灌注的左心室(LV)机械功和能量学的某些作用。SNJ灌注可显著增加中等LV容积的平均收缩末期压和mLVV(总机械能/搏动)的收缩压-容积面积(PVA)(P< 0.01)。心肌每搏平均耗氧量(V ~ o ~ 2)与PVA线性关系的截距(V ~ o ~ 2代表兴奋-收缩偶联和基础代谢中总Ca ~(2+)处理)显著增加(P< 0.01),而V ~ o ~ 2与PVA线性关系的平均斜率不变。用选择性β1受体阻滞剂兰地洛尔(10 μM)预处理可阻断SNJ灌注的这些效应。正常组、40 μM SNJ组和10 μM兰地洛尔+ 40 μM SNJ组之间的平均基础代谢耗氧量无显著差异。我们的结果表明,水溶性SNJ通过β1-肾上腺素能受体介导的机械功和能量学发挥积极作用,与兴奋-收缩偶联中总Ca 2+处理的增强和收缩效率不变有关。在临床环境中,SNJ的这种药理作用作为心脏停搏液的添加剂是有益的。
We have previously shown that a newly developed calpain inhibitor, SNJ-1945 (SNJ), with good aqueous solubility prevents the heart from KCl arrest-reperfusion injury associated with the impairment of total Ca2+handling by inhibiting the proteolysis of α-fodrin as a cardioplegia. The aim of the present study was to investigate certain actions of this calpain inhibitor, SNJ, on left ventricular (LV) mechanical work and energetics in cross-circulated excised rat hearts undergoing blood perfusion with 40 μM SNJ. Mean end-systolic pressure at midrange LV volume and systolic pressure-volume area (PVA) at mLVV (a total mechanical energy/beat) were significantly increased by SNJ perfusion (P< 0.01). Mean myocardial oxygen consumption per beat (V̇o2) intercepts (V̇o2for the total Ca2+handling in excitation-contraction coupling and basal metabolism) of V̇o2-PVA linear relations were significantly increased (P< 0.01) with unchanged mean slopes of V̇o2-PVA linear relations. Pretreatment with the selective β1-blocker landiolol (10 μM) blocked these effects of SNJ perfusion. There were no significant differences in mean basal metabolic oxygen consumption among normal, 40 μM SNJ, and 10 μM landiolol + 40 μM SNJ groups. Our results indicate that water-soluble SNJ exerted positive actions on mechanical work and energetics mediated via β1-adrenergic receptors associated with the enhancement of total Ca2+handling in excitation-contraction coupling and with unchanged contractile efficiency. In clinical settings, this pharmacological action of SNJ is beneficial as an additive agent for cardioplegia.